loading
Schlusskurs vom Vortag:
$3.00
Offen:
$3
24-Stunden-Volumen:
85,253
Relative Volume:
0.68
Marktkapitalisierung:
$33.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.25M
KGV:
-1.6966
EPS:
-1.78
Netto-Cashflow:
$-17.87M
1W Leistung:
-10.65%
1M Leistung:
-24.03%
6M Leistung:
-9.58%
1J Leistung:
+2.37%
1-Tages-Spanne:
Value
$2.86
$3.2323
1-Wochen-Bereich:
Value
$2.86
$3.55
52-Wochen-Spanne:
Value
$2.55
$6.118

Lantern Pharma Inc Stock (LTRN) Company Profile

Name
Firmenname
Lantern Pharma Inc
Name
Telefon
972-277-1136
Name
Adresse
1920 MCKINNEY AVENUE, DALLAS, TX
Name
Mitarbeiter
24
Name
Twitter
@lanternpharma
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
LTRN's Discussions on Twitter

Vergleichen Sie LTRN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LTRN
Lantern Pharma Inc
3.02 33.55M 0 -19.25M -17.87M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.76 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
755.90 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
436.38 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
918.92 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
198.76 42.58B 447.02M -1.18B -906.14M -6.1812

Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-10-07 Eingeleitet H.C. Wainwright Buy

Lantern Pharma Inc Aktie (LTRN) Neueste Nachrichten

pulisher
Nov 21, 2025

Is Lantern Pharma Inc. stock vulnerable to regulatory risksTrade Volume Report & Real-Time Chart Breakout Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Lantern Pharma Inc. stock oversold or undervaluedJuly 2025 News Drivers & Entry and Exit Point Strategies - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Lantern Pharma Inc. stock reacts to global recession fearsMarket Activity Report & Reliable Volume Spike Alerts - newser.com

Nov 21, 2025
pulisher
Nov 19, 2025

Can Lantern Pharma Inc. stock deliver consistent earnings growth2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Lantern Pharma Inc. stock a buy before product launchesTrade Entry Summary & Daily Growth Stock Investment Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Lantern Pharma Inc. stock performs in weak economy2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Lantern Pharma Engages New to The Street for National Media Coverage Featuring Television, Press, Earned Media and Non-Deal Investor Focused Roadshows - Gadsden Times

Nov 18, 2025
pulisher
Nov 16, 2025

Using economic indicators to assess Lantern Pharma Inc. potentialQuarterly Trade Report & Daily Stock Trend Reports - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Lantern Pharma (NASDAQ:LTRN) Will Have To Spend Its Cash Wisely - Yahoo Finance

Nov 15, 2025
pulisher
Nov 15, 2025

Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 15, 2025
pulisher
Nov 14, 2025

Lantern Pharma’s Earnings Call: Progress and Funding Needs - TipRanks

Nov 14, 2025
pulisher
Nov 14, 2025

Lantern Pharma’s Q3 2025: Clinical and AI Progress - TipRanks

Nov 14, 2025
pulisher
Nov 13, 2025

Lantern Pharma (NASDAQ: LTRN) Reports Q3 2025 Results and Highlights AI-Driven Clinical Progress - Digital Journal

Nov 13, 2025
pulisher
Nov 13, 2025

Transcript : Lantern Pharma Inc., Q3 2025 Earnings Call, Nov 13, 2025 - MarketScreener

Nov 13, 2025
pulisher
Nov 13, 2025

Will Lantern Pharma Inc. stock maintain dividend yieldBreakout Watch & Free Risk Controlled Daily Trade Plans - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

LTRN: Pivotal quarter with clinical milestones, AI platform advances, and cash runway into Q3 2026 - TradingView

Nov 13, 2025
pulisher
Nov 13, 2025

Earnings call transcript: Lantern Pharma Q3 2025 sees stock rise after earnings - Investing.com India

Nov 13, 2025

Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Lantern Pharma Inc-Aktie (LTRN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Kreis Leslie W.
10% Owner
Jun 13 '25
Sale
3.09
40,000
123,600
49,957
Fletcher Aaron G.L.
10% Owner
Jun 12 '25
Sale
3.38
60,647
204,987
51,860
Fletcher Aaron G.L.
10% Owner
Jun 11 '25
Sale
3.40
950
3,230
54,746
Fletcher Aaron G.L.
10% Owner
Jun 10 '25
Sale
3.40
16
54
54,791
Kreis Leslie W.
10% Owner
Jun 12 '25
Sale
3.38
60,647
204,987
51,860
Kreis Leslie W.
10% Owner
Jun 11 '25
Sale
3.40
950
3,230
54,746
Kreis Leslie W.
10% Owner
Jun 10 '25
Sale
3.40
16
54
54,791
Fletcher Aaron G.L.
10% Owner
May 27 '25
Sale
3.05
21,037
64,163
56,467
Fletcher Aaron G.L.
10% Owner
May 29 '25
Sale
3.03
20,200
61,206
54,792
Fletcher Aaron G.L.
10% Owner
May 28 '25
Sale
2.87
15,000
43,050
55,753
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):